Hosted on MSN
TransCode Therapeutics shares surge 50% after acquiring Polynoma and securing $25 million financing
TransCode Therapeutics (NASDAQ:RNAZ) shares jumped 50% on Wednesday after the company announced the acquisition of Polynoma alongside a $25 million strategic investment from a subsidiary of CK Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results